Endocrinology, Diabetes & Metabolism Case Reports (Dec 2023)

Barakat syndrome diagnosed decades after initial presentation

  • Umberto Spennato,
  • Jennifer Siegwart,
  • Britta Hartmann,
  • Elisabeth Julia Fischer,
  • Cecilia Bracco,
  • Joel Capraro,
  • Beat Mueller,
  • Philipp Schuetz,
  • Andreas Werner Jehle,
  • Tristan Struja

DOI
https://doi.org/10.1530/EDM-23-0018
Journal volume & issue
Vol. 1, no. 1
pp. 1 – 6

Abstract

Read online

Barakat syndrome, also called HDR syndrome, is a rare genetic disorder encompassing hypoparathyroidism (H), sensorineural deafness (D) and renal disease (R). A 64-year-old woman was referred to our endocrinology clinic for a switch in treatment (from dihydrotachysterol to calcitriol). She had progressive sensorineural deafness since the age of 18 and idiopathic hypoparathyroidism diagnosed at age of 36. Her medical history included osteoporosis with hip/spine fractures, nephrolithiasis and a family history of hearing loss, osteoporosis and kidney disease. The patient’s clinical presentation indicated Barakat syndrome. Genetic analysis found a GATA3:c.916C>T nonsense variant. Further tests such as audiometry, labs and renal imaging supported the diagnosis. Due to rarity and manifold symptoms, diagnosis can be challenging. Optional GATA3 testing was suggested in 2018, except in cases of isolated sensorineural deafness or renal disease with pertinent family history. In isolated ‘H’ cases without ‘D’ and ‘R’, GATA3 studies are not required, as no haploinsufficiency cases were reported. Given the rise in genetic disorders, physicians should consistently consider rare genetic disorders in patients with suggestive symptoms, even decades after onset. Although diagnosis might not always impact management directly, it aids patients in accepting their condition and has broader family implications.